Literature DB >> 8124807

Reconsideration of criteria for the Fontan operation. Influence of pulmonary artery size on postoperative hemodynamics of the Fontan operation.

H Senzaki1, T Isoda, A Ishizawa, T Hishi.   

Abstract

BACKGROUND: The outcome of the Fontan operation largely depends on the selection of patients because this procedure is a physiological correction. Among the several selection criteria for the Fontan operation, the importance of adequate size of the pulmonary artery remains controversial. In this series, in order to clarify whether the pulmonary artery size is indispensable or not as one of the selection criteria for the Fontan operation, we considered the physiological meaning of pulmonary artery size and investigated how it influenced postoperative hemodynamics of the Fontan operation. METHODS AND
RESULTS: In congenital heart disease of decreasing pulmonary blood flow, 40 patients were examined for this analysis. Pulmonary artery indexes (cross-sectional area of the right and left pulmonary arteries divided by body surface area) were measured as the expression of pulmonary artery size, and the relations of pulmonary artery index (PAI) to pulmonary vascular resistance (Rp) and compliance (Cp) were studied. There was no significant correlation between PAI and Rp, whereas a significant correlation was found between PAI and Cp (r = .71, P = .001). Furthermore, Cp influenced postoperative hemodynamics of the Fontan operation by affecting the peak central venous pressure (pCVP) and total impedance, which was the afterload to the ventricle. Impedance increased abruptly when PAI was < approximately 100 mm2/m2.
CONCLUSIONS: The smaller pulmonary artery size causes more disadvantageous hemodynamics after the Fontan operation, with resultant effects of the rise in pCVP and the increase in afterload to the single ventricle.

Entities:  

Mesh:

Year:  1994        PMID: 8124807     DOI: 10.1161/01.cir.89.3.1196

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Geometry and dimensions of the pulmonary artery bifurcation in children and adolescents: assessment in vivo by contrast-enhanced MR-angiography.

Authors:  Zita Knobel; Christian J Kellenberger; Thomas Kaiser; Manuela Albisetti; Eva Bergsträsser; Emanuela R Valsangiacomo Buechel
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-21       Impact factor: 2.357

2.  Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation.

Authors:  G H Tatum; G Sigfússon; J A Ettedgui; J L Myers; S E Cyran; H S Weber; S A Webber
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

3.  Surgical preconditioning and completion of total cavopulmonary connection by interventional cardiac catheterisation: a new concept.

Authors:  G Hausdorf; M Schneider; W Konertz
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

4.  Cavopulmonary anastomosis without cardiopulmonary bypass.

Authors:  Ezzeldin A Mostafa; Ashraf A H El Midany; Mahmoud M Zalat; Ahmed Helmy
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-18

5.  Fontan Operation in a Patient with Severe Hypoplastic Right Pulmonary Artery, Single Ventricle, and Heterotaxy Syndrome.

Authors:  Jun-Yen Pan; Chu-Chuan Lin; Jen-Ping Chang
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

Review 6.  Decision-Making for Surgery in the Management of Patients with Univentricular Heart.

Authors:  Ryan Robert Davies; Christian Pizarro
Journal:  Front Pediatr       Date:  2015-07-27       Impact factor: 3.418

Review 7.  Predictive Models for Pulmonary Artery Size in Fontan Patients.

Authors:  Akash Gupta; Chris Gillett; Patrick Gerard; Michael M H Cheung; Jonathan P Mynard; Ethan Kung
Journal:  J Cardiovasc Transl Res       Date:  2020-04-04       Impact factor: 4.132

Review 8.  Catheter hemodynamic assessment of the univentricular circulation.

Authors:  Oliver Stumper; Gemma Penford
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.